Related Experiment Videos
Enhanced malignant tumorigenesis in Cdk4 transgenic mice
Paula L Miliani de Marval1, Everardo Macias, Claudio J Conti
1Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA.
Oncogene
|December 3, 2003
Summary
Overexpression of cyclin-dependent kinase-4 (CDK4) in mice accelerates skin tumor progression to squamous cell carcinomas. CDK4, not cyclin D1, demonstrates higher oncogenic activity, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Previous studies linked cyclin-dependent kinase-4 (CDK4) overexpression to skin abnormalities like hyperplasia and fibrosis.
- The oncogenic potential of CDK4 in skin tumor formation remained to be fully elucidated.
Purpose of the Study:
- To investigate the role of forced CDK4 expression in skin tumor development and malignant progression.
- To compare the oncogenic activity of CDK4 with cyclin D1 in skin carcinogenesis.
Main Methods:
- Utilizing transgenic mouse models with forced CDK4 expression.
- Employing an initiation-promotion protocol for skin tumor induction.
- Conducting histopathological analysis and biochemical assays of tumors.
Main Results:
- CDK4 overexpression significantly increased the rate of malignant progression to squamous cell carcinomas (SCC).
- Transgenic mice developed tumors in initiated skin without promotion, indicating CDK4 can replace tumor promoter functions.
- CDK4 overexpression led to the sequestration of CDK2 inhibitors (p27Kip1, p21Cip1), suggesting indirect CDK2 activation in tumor development.
Conclusions:
- CDK4 exhibits higher oncogenic activity than cyclin D1 in skin carcinogenesis.
- CDK4 plays a critical role in the malignant progression of skin tumors.
- CDK4 represents a potential therapeutic target for skin cancer treatment.